BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk

See teave on mõeldud ainult uurimis- ja hariduslikel eesmärkidel. Ei ole meditsiiniline soovitus. Tooted ei ole heaks kiidetud kasutamiseks inimestel. Terviseküsimustes pöördu arsti poole.

Leksikon

Kamagra Oral Jelly (Sildenafil)

Sildenafil as a gel in a sachet: same active substance as the tablet, same rules, just no score line and no studies on the form itself.

9 min read 10 sources

Large molecule model of blue, light blue, white and one yellow sphere above a white podium with a glowing light blue rim, blurred glass flasks behind it in a bright lab
Compound approved · since 1998

Summary

At a glance

Sources checked on 26 Oct 2026

Successful attempts in the approval study
69 %

versus 22 percent on placebo, study with tablets1

Better erections after 52 weeks
89 %

self-assessment in four open-label extension studies with 1008 men2

Bioavailability
41 %

share that reaches the blood after swallowing, measured with tablets3

Half-life
~4 hours

also applies to the active breakdown product7

Studies on the gel form
0 studies

no published study on the gel in a sachet, as of 26 Oct 20269

  • Kamagra Oral Jelly contains sildenafil as a gel in a sachet. The compound inhibits the enzyme PDE5, the messenger cGMP lasts longer in the erectile tissue and more blood flows in.107
  • Without sexual arousal nothing happens according to the label: the trigger remains the body's own nitric oxide.7
  • In the approval study with tablets 69 percent of attempts succeeded versus 22 percent on placebo. After 52 weeks 89 percent reported better erections.12
  • There is no study of the gel itself. An oral film matched the tablet in studies, a high-fat meal delayed the peak with both.5639
  • Nitrates are excluded according to the label. According to ChEMBL sildenafil has been approved since 1998. Everything here is the state of research, not a recommendation.7410
Profiil

Updated October 2026

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~4 hours

Half-life ~4 hours
After 8 hours: 25 %
Hour 4 · 50 %Hour 8 · 25 %Hour 12 · 12.5 %Hour 20 · 3.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 3 to 5 hours, we calculate with the middle.

Class
PDE-5 inhibitor

sildenafil, as a gel in a sachet

Use
Oral

on demand, about 1 hour beforehand, at most once in 24 hours

Half-life
About 3 to 5 hours

effect window roughly 4 to 6 hours

Onset
Peak plasma level after about 1 hour fasted, about 1 hour later after a high-fat meal
Form
Sachet with 5g of gel and 100mg sildenafil, 7 flavours per box
Status
Active substance clinically approved

no published comparative data on the gel form itself

Sizes
100 mg

1 size in the shop

Sisu 15 sections
  1. Lühidalt
  2. What is Kamagra Oral Jelly?
  3. How it works
  4. Pharmacokinetics: onset, food, half-life
  5. Gel instead of tablet: what changes and what does not
  6. Use and dosing
  7. What the research shows
  8. Uuringute seis
  9. Interactions and contraindications
  10. Side effects
  11. Storage
  12. Seotud ühendid
  13. KKK
  14. Mõisted
  15. Allikad

What is Kamagra Oral Jelly?

Kamagra Oral Jelly is sildenafil citrate in gel form. Instead of a pressed tablet, the active substance sits in a sachet of 5g flavoured gel, 100mg sildenafil per sachet, seven sachets in seven flavours per box. It is made by Ajanta Pharma, the manufacturer behind the Kamagra brand.

Pharmacologically this is the same PDE-5 inhibitor that became famous as a tablet under the name Viagra and ranks among the most thoroughly studied drugs there are. The only thing that changes is the dosage form: a gel you can swallow without water, which does not come in dose steps. Everything the lexicon says about sildenafil therefore applies here too. The points specific to the gel get their own section below.

This information is for research and educational purposes only. No medical advice.

How it works

During sexual arousal, nerve endings and the vessel lining in the erectile tissue release nitric oxide. That activates guanylate cyclase, cyclic GMP is produced, smooth muscle relaxes, the arteries widen and the swelling tissue compresses the draining veins. The enzyme phosphodiesterase type 5 breaks cGMP down again and ends the process.

Sildenafil blocks exactly that enzyme. cGMP persists longer, the signal is amplified and the erection comes more easily and holds more reliably. The key point is that sildenafil does not start anything, it only amplifies: without arousal no nitric oxide is released, no cGMP is made and there is nothing to protect. That is why the substance is not an aphrodisiac and does not change libido.

Sildenafil is not perfectly selective. To a lesser degree it also inhibits PDE6 in the retina, which explains the transient blue tinge in vision. Through the same cGMP pathway it acts on blood vessels throughout the body. That is where headache, flushing and the mild drop in blood pressure come from. The dangerous interaction with nitrates comes from the same place.

Where it acts

Where sildenafil acts

Tap a point or a card. Colour = PDE5, grey = observed in studies.

  1. Erectile tissue and vessels

    More cGMP, smooth muscle relaxes, more blood flows in7

    PDE5
  2. Small intestine

    Uptake after swallowing, 41 percent reach the blood3

    Observed in trials
  3. Eye

    Colour tinge in vision, because PDE6 of the retina is also slightly inhibited7

    Observed in trials
  4. Head

    Headache in 16 versus 4 percent7

    Observed in trials
  5. Liver

    Breakdown mainly via CYP3A4, an active breakdown product forms7

    Observed in trials

Targets in the ChEMBL database10

Compound CHEMBL1737: one recorded mechanism, Inhibitor, direct binding.

Phosphodiesterase 5A
Gene
PDE5A
UniProt
O76074
ChEMBL
CHEMBL1827
Action
Inhibitor, direct binding
Transparent vessel with pink muscle fibres in its wall, inside it grey enzyme shapes docked by blue molecule models, surrounded by glowing light blue dots
Sildenafil blocks PDE5, the signal in the vessel wall lasts longer. Symbolic image.

Pharmacokinetics: onset, food, half-life

Nichols and colleagues (British Journal of Clinical Pharmacology 2002) measured the kinetics of the tablet in healthy men: absolute bioavailability is about 41 percent. The peak plasma level is reached roughly one hour after a fasted dose. A high-fat meal pushes the peak back by about an hour and lowers it by 29 percent, while total exposure drops by only 11 percent. For a drug that is supposed to work at a particular time, the delayed peak is the part that matters.

Between 25 and 200mg exposure rises slightly more than proportionally, so doubling the dose gives roughly 2.1 to 2.2 times the level. Clearance runs mainly through CYP3A4 and to a lesser extent CYP2C9. It produces the active metabolite N-desmethyl-sildenafil with about half the potency. The terminal half-life is 3 to 5 hours according to the prescribing information. The practical effect window is around 4 to 6 hours.

In older adults and in hepatic or severe renal impairment, clearance is lower and levels are higher. The prescribing information advises starting at 25mg in hepatic and severe renal impairment and with strong CYP3A4 inhibitors. The US label adds age 65 and over.

Gel instead of tablet: what changes and what does not

There are no published pharmacokinetic data on the gel itself. That belongs at the top: every number above comes from tablets. The idea that the gel kicks in faster or works harder is a marketing claim, not a measured quantity. Sildenafil is absorbed in the small intestine, not through the lining of the mouth. A swallowed gel ends up in the same place as a dissolved tablet.

The best available guidance comes from other dosage forms that are not swallowed as a tablet. Radicioni and colleagues (Drug Design, Development and Therapy 2017) compared a 100mg sildenafil orodispersible film against the film-coated tablet in 53 healthy men: the plasma curves were nearly superimposable, peak and total exposure were bioequivalent and no advantage in onset appeared. Pham and colleagues (Sexual Medicine 2025) showed for the same film that a high-fat meal delays the peak by almost an hour and a half and lowers it by 45 percent, which is the same food effect seen with the tablet. For the gel, the same behaviour is the plausible assumption, but no more than that.

What genuinely changes is the handling. The gel needs no water and is more comfortable for people who struggle with tablets. In return it has no score line: one sachet is a single 100mg unit. Anyone who wants 50mg squeezes out half and estimates. That is less precise than splitting a tablet. An opened sachet should not sit around for long.

Comparison

PDE5 inhibitors in the lexicon

All inhibit the same enzyme. Kamagra Oral Jelly is sildenafil in a different form, the tablet sits next to it. Tap a card to open its entry.

Simplified: same compound as the sildenafil tablet, just without a score line. 107

Use and dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts

What the research shows

Goldstein and colleagues (New England Journal of Medicine 1998) supplied the registration data: in a 24-week dose-response study in 532 men, 25, 50 and 100mg improved erectile function in a dose-dependent way. In a 12-week flexible-dose study in 329 further men, 69 percent of all attempts in the final four weeks were successful versus 22 percent on placebo. Headache, flushing and heartburn occurred in 6 to 18 percent. Of the men, 92 percent completed the subsequent 32-week extension.

Steers and colleagues (International Journal of Impotence Research 2001) pooled four open-label extension studies with 1008 patients over 36 to 52 weeks at flexible doses of 25 to 100mg. After 52 weeks, 89 percent reported that their erections had improved. The effect did not fade over time. Cardiovascular adverse events such as hypertension or tachycardia stayed below one percent. Because of adverse events, 2 percent discontinued.

There is no study on the gel form itself. What speaks for it is solely the evidence on the active substance and the bioequivalence of other non-tablet oral forms (see above). Put honestly: the active substance is as well evidenced as almost any drug, the dosage form is not.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

Share of successful attempts1

329 men, flexible dose escalation over 12 weeks, last four weeks, tablets

Dose-escalation study1
Placebo 22%
Sildenafil (tablet) 69%

In the second study with 532 men erection improved with increasing dose. The gel form was never tested in such a study, the values apply to the compound.

Share with better erections2

Four open-label extension studies, 1008 men, flexible dose, tablets

After 36 weeks2
Sildenafil (tablet) 92%
After 52 weeks2
Sildenafil (tablet) 89%

Open-label studies without placebo, the men knew what they were taking. 2 percent stopped because of side effects, circulatory side effects were below 1 percent.

What a high-fat meal changes36

Change compared with fasting, tablet and oral film, in percent

Peak level, tablet3 34 healthy men
Sildenafil (tablet) -29%
Total exposure, tablet3 34 healthy men
Sildenafil (tablet) -11%
Peak level, oral film6 45 healthy men
Sildenafil (oral film) -45%

With the tablet the peak came about 1 hour later after a meal, with the oral film 1.45 hours later. According to the study total exposure of the film was unchanged. When fasted, film and tablet were equivalent (53 men). There is no measurement for the gel in a sachet.

Transparent curved blood vessel with red blood cells and bright streams of light against a bright lab background
More blood flow in the tissue is the core of the effect. Symbolic image.

Research status

Where the research stands

Sildenafil has been approved since 1998, the registry lists 494 trials with the compound. None is on the gel in a sachet. Shown are trials on other forms that are not swallowed as a tablet and three post-approval trials. As of 26 Oct 2026. 8

  1. Preclinical Principle: inhibition of phosphodiesterase 5
  2. Phase 1 1 trial, 1 completed
  3. Phase 2 no registered trial
  4. Phase 3 1 trial, 1 completed
  5. Approval since 1998
488 participants in phase 3 Compound approved: ChEMBL lists sildenafil with phase 4 as the highest phase and first approval in 1998. The gel form in a sachet has no study data of its own.10
Show all 5 trials on a timelineHide timeline 5 completed 0 running 0 with results
Phase 3
Phase 4
Without phase

Bar: start to primary endpoint (planned for running trials). Green = completed, blue = progress until 26 Oct 2026. Phase 1: 1 trial on safety and pharmacokinetics, not shown as bars.

Interactions and contraindications

The most important rule of this drug class is not negotiable: sildenafil must never be taken together with nitrates. That includes heart nitrates such as nitroglycerin, isosorbide dinitrate and isosorbide mononitrate, but also poppers (amyl nitrite and other alkyl nitrites). Webb and colleagues (American Journal of Cardiology 1999) measured this in healthy men: after only 25mg sildenafil, systolic blood pressure fell four times as much in response to a nitroglycerin tablet as on placebo. The subjects also tolerated a nitroglycerin infusion markedly worse. Both substances act through cGMP, so the effects do not add up, they multiply. The same applies to riociguat.

  • Alpha blockers (tamsulosin, alfuzosin, doxazosin): additional blood pressure drop, especially on standing. The prescribing information advises being stable on the alpha blocker first and starting at 25mg.
  • Other blood pressure drugs: in the Webb study, 100mg sildenafil lowered blood pressure in men on amlodipine by a further 8/7 mmHg or so, additive rather than excessive. Anyone on blood pressure medication should know this and measure.
  • CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole, erythromycin, clarithromycin, grapefruit juice) raise sildenafil levels markedly, with ritonavir several-fold. There the prescribing information names 25mg as the starting dose, which is where the TPD line stays. With ritonavir no more than 25mg in 48 hours.
  • CYP3A4 inducers such as rifampicin lower levels and weaken the effect.
  • Other PDE-5 inhibitors (tadalafil, vardenafil) are not to be combined, that is a double dose with a double side effect profile.
  • Cardiovascular status: with unstable angina, recent infarction or stroke, severe heart failure or uncontrolled blood pressure, the question is not the drug but whether physical exertion is advisable at all. That belongs with a doctor.

Side effects

  • Headache, flushing, heartburn: the three most common, at 6 to 18 percent in the registration trial, dose-dependent and mostly mild. They come straight from the vasodilation.
  • Stuffy nose: regularly reported in the long-term studies, also explained by the vessels.
  • Visual disturbances: blue tinge, increased light sensitivity or blurred vision, transient, via PDE6 inhibition in the retina. A sudden loss of vision in one eye is an emergency by contrast. Isolated cases of impaired blood supply to the optic nerve are described.
  • Dizziness and blood pressure drop: mild, stronger in combination with larger amounts of alcohol or blood-pressure-lowering drugs.
  • Priapism: rare. An erection lasting longer than four hours is a urological emergency, because the erectile tissue is otherwise damaged.
  • Sudden hearing loss: reported in isolated cases, a reason to stop and a case for assessment.
  • Cardiovascular events: below one percent in the long-term data from Steers. Serious events in the literature are almost always tied to nitrates or pre-existing heart disease.

Specific to the gel: it contains flavourings, sweeteners and colourants that a tablet does not. Anyone sensitive to those has an extra source of intolerance here that has nothing to do with the active substance. And because a sachet is 100mg, side effects with the gel land on the maximum dose more often than with a tablet that is simply split.

Tolerability

Side effects compared with placebo

Values from the tablet studies in the US label. There are no separate figures for the gel.

4 of 100 Placebo
16 of 100 Sildenafil (tablet)
Event PlaceboSildenafil (tablet)
Headache7 4%16%
Flushing7 1%10%
Indigestion7 2%7%
Nasal congestion7 2%4%
Abnormal vision7 0%3%
Abnormal vision by fixed dose7 1%0%

The visual disturbance was mostly a colour tinge, more light sensitivity or blurred vision, mild and transient. One sachet equals the highest study dose. Taking it whole puts you in the group with the most side effects.7

Storage

Store dry, below 30 degrees Celsius and protected from light, with the sachets left in the box. Keep it out of heat, such as a car or bathroom, because the gel changes consistency with temperature swings. Use opened sachets within a short time and do not leave them half-empty for days. Keep out of reach of children, as the flavours make the gel more appealing to children than a tablet.

Related

Related compounds

Same targets, blends with Kamagra Oral Jelly (Sildenafil) or a different path: all in the TPD lexicon.

FAQ

Common questions about Kamagra Oral Jelly (Sildenafil)

Short answers, each backed by the sources below.

Is the gel different from the sildenafil tablet?

The compound is the same, only the form changes. There is no published study of the gel in a sachet. An oral film, which is also not swallowed as a tablet, gave almost identical blood levels to the film-coated tablet in 53 healthy men. A faster onset was not found there.59

Is sildenafil approved?

Yes. ChEMBL lists sildenafil as an approved compound with first approval in 1998. On ClinicalTrials.gov 494 trials list sildenafil (as of 26 October 2026), none of them tests the gel in a sachet.1089

What did the approval study show?

Goldstein and colleagues tested tablets in two studies. In the first with 532 men erection improved with increasing dose up to the highest study dose of 100 mg. In the second with 329 men 69 instead of 22 percent of attempts succeeded. In four extension studies with 1008 men the effect did not wane over 52 weeks.12

Why does food matter?

After a high-fat meal the peak level with the tablet came about an hour later and was 29 percent lower, total exposure fell by only 11 percent. With the oral film the peak shifted by 1.45 hours and fell by 45 percent. The same behaviour is plausible for the gel, but it has not been measured.36

Why never together with nitrates?

Nitrates act via the same cGMP pathway. In a study in healthy men systolic blood pressure fell four times as much on a nitroglycerin tablet with sildenafil as with placebo. Therefore organic nitrates in any form are excluded according to the label, as are drugs such as riociguat. Caution applies with alpha blockers and other blood pressure drugs.47

Where does the colour tinge in vision come from?

Sildenafil inhibits PDE5 only about ten times more strongly than PDE6, an enzyme of the retina. At the highest fixed study dose 11 percent reported abnormal vision, 1 percent on placebo. For sudden loss of vision the label says to stop at once and seek medical help.7

What if an erection does not subside?

If an erection lasts longer than 4 hours, the label calls it an emergency. A higher level, for example from strong CYP3A4 inhibitors, makes a drop in blood pressure, fainting and prolonged erections more likely.7

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

Bioavailability
Share of a swallowed compound that reaches the blood unchanged. For sildenafil about 41 percent.
Bioequivalence
Two forms of the same compound give equally high blood levels in the same time, within fixed limits.
cGMP
Cyclic guanosine monophosphate, a messenger inside the cell. It relaxes the smooth muscle of the vessels.
CYP3A4
Liver enzyme that breaks down many compounds. If something inhibits it, the level of other drugs rises.
Nitrates
Heart drugs such as nitroglycerin that release nitric oxide. Together with PDE5 inhibitors blood pressure can fall dangerously.
Nitric oxide
A gas released by nerves and the vessel wall on arousal. It starts the production of cGMP.
PDE5
Phosphodiesterase 5, an enzyme that breaks down the messenger cGMP in the erectile tissue. Sildenafil inhibits it.
PDE6
Related enzyme in the retina. Its slight inhibition explains the temporary colour tinge in vision.
Peak level
Highest concentration in the blood after an intake. The time to reach it is called Tmax.
Priapism
Erection that does not subside for hours. An emergency, because the tissue can be damaged.

Tõendid

Allikad

Show all 10 sourcesHide sources 6 Studies2 Trial registry2 Database checked 26 Oct 2026

Studies

  1. Approval studies of sildenafil in erectile dysfunction

    Goldstein et al., New England Journal of Medicine, 1998

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. Four open-label long-term studies with 1008 men

    Steers et al., International Journal of Impotence Research, 2001

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. Tablet kinetics: bioavailability, food, dose

    Nichols et al., British Journal of Clinical Pharmacology, 2002

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  4. Interaction with nitroglycerin and amlodipine

    Webb et al., American Journal of Cardiology, 1999

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  5. Oral film versus film-coated tablet in 53 healthy men

    Radicioni et al., Drug Design, Development and Therapy, 2017

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  6. Food effect with the sildenafil oral film

    Pham et al., Sexual Medicine, 2025

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Trials on sildenafil on ClinicalTrials.gov

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2
  2. Registry search for sildenafil as film, gel or orodispersible form (no gel in a sachet)

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. US prescribing information for sildenafil

    DailyMed, U.S. National Library of Medicine (Stand 11/2023)

    Checked 26 Oct 2026 via DailyMed
  2. Mechanism and approval in ChEMBL

    ChEMBL, EMBL-EBI (CHEMBL192, Mechanismus am Citrat CHEMBL1737)

    Checked 26 Oct 2026 via ChEMBL

Poes

Kamagra Oral Jelly (Sildenafil) in the catalog

Suurused, hinnad ja tarneajad on tootelehel.

Toote juurde